RPS, the market leading global provider of disruptive and innovative outsourcing Clinical Development Solutions, provides comprehensive Phase I-IV services to meet the evolving needs of the Biopharmaceutical, Medical Device and Diagnostic industries, customized by customer type (large, mid-size, and small). Built organically, RPS is the fastest growing top 10 global Clinical Research Organization (CRO), with more than 5,000 employees and operations in more than 64 countries with proprietary internal structures. These structures provide both RPS and its partners greater development flexibility and growth. RPS is uniquely positioned to provide the following customized clinical development solutions:
Large Organizations: RPS provides innovative, Embedded, portfolio-wide clinical development solutions delivering multi-million dollar cost savings, greater quality and the ability to manage more within their portfolio while retaining strategic control and effectively managing regulatory risk.
Midsize Organizations: RPS has leveraged its market leading Embedded Clinical Development Solutions expertise providing an innovative model that enables the efficient internal development of a midsize company’s product portfolio with greater control and flexibility, accelerated development timelines and substantially reduced costs.
Virtual/Specialty Organizations: RPS provides a comprehensive project based delivery solution with market leading full service processes and tools. Our in-house drug development expertise combined with outstanding project management means that our clients achieve superior execution on efficiently designed studies. RPS recruits in excess of 100,000 patients a year with performance ahead of industry leading benchmarks.
520 Virginia Dr.
RPS - http://www.rpsweb.com